Treatment of HR-positive Her2-negative advanced breast cancer
Study design, with clearly defined demographics and outcomes, facilitates decision-making
3 COMENTÁRIOSSee more Clinical Trials
Immunotherapy in gastric cancer
The Catcher in the Rye
5 COMENTÁRIOS
Controversies in the treatment of breast cancer with CDK4/CDK6 inhibitors
The ebb and flow of adjuvant trials
0 COMENTÁRIOS
Adjuvant nivolumab in cancer of the esophagus and esophagogastric junction
Interim analysis of the CheckMate 577 study
1 COMENTÁRIOS